Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Titel:
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Auteur:
Markman, B. Tabernero, J. Krop, I. Shapiro, G.I. Siu, L. Chen, L.C. Mita, M. Melendez Cuero, M. Stutvoet, S. Birle, D. Anak, Ö. Hackl, W. Baselga, J.